Cancer Immunotherapy

Advertisement

cGxPJobs Banner

.Clinical Bio-Pharma

Oncolytics Biotech Shows Favorable Safety for Pelareorep in GI Tumors

SAN DIEGO, Sept. 2, 2025 – Oncolytics Biotech® Inc. (Nasdaq: ONCY), a clinical-stage immunotherapy company, announced updated clinical safety...

By cGxPwire Editor
September 2, 2025

Read More

Advertisement

cGxPJobs

Directory